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A 73-year-old non-smoking female was seen in
the outpatient clinic following discovery of a
solitary mid-zone opacity on chest radiograph.
Computerised tomographic (CT) imaging raised
the possibility of an early lung cancer and subse-
quent fine needle aspiration was non-diagnostic.
Positron emission tomography (PET) showed iso-
lated increased uptake of 18F-fluorodeoxyglu-
cose (FDG) corresponding to the lesion on CT
imaging (Fig. 1). A video-assisted thorascopic
wedge biopsy of the middle lobe was performed
and peri-operative frozen section revealed his-
tological changes consistent with pulmonary
amyloid.
PET imaging is a useful diagnostic and staging
tool in the evaluation of suspected or known
bronchial carcinoma.1 As a consequence of in-
creased metabolic and cellular activity of neoplas-
tic tissue, FDG enters tumour cells and becomes
trapped. This in turn enables PET images to be
constructed to highlight areas of enhanced FDGitron emission tomographic imaging showing in
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med.2005.04.030uptake. As with all diagnostic modalities, false
positives can occur although the specificity is
considered to be reasonably high with PET scan-
ning.1 Known causes of false positives include
infection such as with tuberculosis, aspergillosis,
histoplasmosis and inflammatory disorders. This
case highlights the importance of obtaining histo-
logical confirmation in patients with suspected
malignancy—even in patients with a positive PET
image—and compliments the paucity of case
reports2,3 where preferential FDG uptake has
occurred in patients turning out to have pulmonary
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